Controlling hepatitis C in Rwanda: a framework for a national response

With the introduction of direct-acting antiviral drugs, treatment of hepatitis C is both highly effective and tolerable. Access to treatment for patients, however, remains limited in low- and middle-income countries due to the lack of supportive health infrastructure and the high cost of treatment....

Descripción completa

Detalles Bibliográficos
Autores principales: Mbituyumuremyi, Aimable, Van Nuil, Jennifer Ilo, Umuhire, Jeanne, Mugabo, Jules, Mwumvaneza, Mutagoma, Makuza, Jean Damascene, Umutesi, Justine, Nsanzimana, Sabin, Gupta, Neil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Health Organization 2018
Materias:
Policy & Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791867/
https://www.ncbi.nlm.nih.gov/pubmed/29403100
http://dx.doi.org/10.2471/BLT.16.183772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791867/
https://www.ncbi.nlm.nih.gov/pubmed/29403100
http://dx.doi.org/10.2471/BLT.16.183772

Ejemplares similares